KZA 0.00% 8.0¢ kazia therapeutics limited

Selling the PRV, if we get it, will be necessary if the right...

  1. 2,988 Posts.
    lightbulb Created with Sketch. 258
    Selling the PRV, if we get it, will be necessary if the right deal does not materialise and management decides to take paxalisib all the way to market. This part is expensive. However, the business model is not supposed to do this part.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.